Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2 ; volume:10 ; number:1 ; day:30 ; month:6 ; year:2020 ; pages:1-11 ; date:12.2020
Scientific reports ; 10, Heft 1 (30.6.2020), 1-11, 12.2020
- Urheber
-
Roh, Jin
Cho, Hyungwoo
Yoon, Dok Hyun
Hong, Jung Yong
Lee, A-Neum
Eom, Hyeon Seok
Lee, Hyewon
Park, Weon Seo
Han, Jae Ho
Jeong, Seong Hyun
Park, Joon Seong
Pak, Hyo-Kyung
Kim, So-Woon
Kim, Sang-Yeob
Suh, Cheolwon
Huh, Jooryung
Park, Chan-Sik
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-67738-4
- URN
-
urn:nbn:de:101:1-2020082100394117965597
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Roh, Jin
- Cho, Hyungwoo
- Yoon, Dok Hyun
- Hong, Jung Yong
- Lee, A-Neum
- Eom, Hyeon Seok
- Lee, Hyewon
- Park, Weon Seo
- Han, Jae Ho
- Jeong, Seong Hyun
- Park, Joon Seong
- Pak, Hyo-Kyung
- Kim, So-Woon
- Kim, Sang-Yeob
- Suh, Cheolwon
- Huh, Jooryung
- Park, Chan-Sik
- SpringerLink (Online service)
Ähnliche Objekte (12)
GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner
Bcl2 inhibition of mitochondrial DNA repair
Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients
CD23-positive, BCL2-Rearrangement-negative Keimzentrumslymphome
BCL2 genotypes and prostate cancer survival
Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1
Phenotyping of cancer-associated somatic mutations in the BCL2 transmembrane domain
A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients
Computational study on novel natural inhibitors targeting BCL2
Primary follicular lymphoma of the epididymis positive for t(14;18)(q32;q21)/IGH- BCL2 and negative for BCL2 protein expression: a case report
Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner
Bcl2 inhibition of mitochondrial DNA repair
Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients
CD23-positive, BCL2-Rearrangement-negative Keimzentrumslymphome
BCL2 genotypes and prostate cancer survival
Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1
Phenotyping of cancer-associated somatic mutations in the BCL2 transmembrane domain
A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients
Computational study on novel natural inhibitors targeting BCL2
Primary follicular lymphoma of the epididymis positive for t(14;18)(q32;q21)/IGH- BCL2 and negative for BCL2 protein expression: a case report
Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner
Bcl2 inhibition of mitochondrial DNA repair
Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients
CD23-positive, BCL2-Rearrangement-negative Keimzentrumslymphome
BCL2 genotypes and prostate cancer survival
Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1
Phenotyping of cancer-associated somatic mutations in the BCL2 transmembrane domain
A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients
Computational study on novel natural inhibitors targeting BCL2
Primary follicular lymphoma of the epididymis positive for t(14;18)(q32;q21)/IGH- BCL2 and negative for BCL2 protein expression: a case report